1Storey E, Cappai R. The amyloid precursor protein of Alzheimer′s disease and the Aβ peptide[J]. Neuropathol Appl Neurobiol, 1999, 25(2):81-97.
2Esler WP, Wolfe MS. A portrait of Alzheimer secretases -new features and familiar faces [J]. Science, 2001, 293(5534): 1449-1454.
3Olson RE, Copeland RA. Progress towards testing the amyloid hypothesis: inhibitors of APP processing[J]. Curr Opin Drug Discov Devel, 2001, 4(4):390-401.
4Buxbaum JD, Liu KN, Luo Y. Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor[J]. J Biol Chen, 1998, 273(43) :27765-27767.
5Vassar R, Bennett BD, Babu-Kahn S, et al. Beta-secretase cleavage of Alzheimer′s amyloid precursor protein by the transmembrane aspartic protease BACE[J]. Science, 1999,286(5440) :735-741.
6Sinha S, Anderson JP, Barbour R, et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain[J]. Nature, 1999, 402(6761) :537-540.
8Hussain I, Powell D, Howlett DR, et al. Identification of a novel aspartic protease (Asp 2) as beta-secretase[J]. Mol Cell Neurosci, 1999, 14(6) :419-427.
9Lin X, Koelsch G, Wu S, et al. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid prescursor protein[J]. Proc Natl Acad Sci USA, 2000, 97(4): 1456-1460.
10Ghosh AK, Shin D, Downs D, et al. Design of potent inhibitors for human brain memapsin 2 (beta-secretase) [J].JAm Chem Soc, 2000, 122:3522-3523.
6Hardy J, Selkoe DJ. The amyloid hypothese of Alzheimer's disease: Progress and problems on the road to therapeutics. Science, 2002; 297:353-356.
7Gamma- sectetase inhibitors both impair notchl protelysis andnuclear tranlocation with relative preservation of notchl sigaling. J Neurochem, 2002; 75 (2): 583-593.
8Ronald BD, Kelly RB, David JC et al. Peripheral anti - A antibody alters CNS and plasma A clearance and decreases brain A burden in mouse model of Alzheimer's disease. Proc Natl Acad Sci USA, 2001; 98 (13): 8850-8855.
9Weiner HL, Lemere CA, Maron R et al. Nasal adminidtation of amyloid- beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease. Ann Neurol, 2000; 48(4) : 567-579.
10Morgan D, Diammond DM, gottschall PE et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature, 2000; 408 (6815): 982-985.
